Literature DB >> 21731908

Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer.

Alexandra Mj Langers1, Hein W Verspaget, Daniel W Hommes, Cornelis Fm Sier.   

Abstract

Matrix metalloproteinases (MMPs) are implicated in cancer development and progression and are associated with prognosis. Single-nucleotide polymorphisms (SNPs) of MMPs, most frequently located in the promoter region of the genes, have been shown to influence cancer susceptibility and/or progression. SNPs of MMP-1, -2, -3, -7, -8, -9, -12, -13 and -21 and of the tissue inhibitor of metalloproteinases (TIMPs) TIMP-1 and TIMP-2 have been studied in digestive tract tumors. The contribution of these polymorphisms to the cancer risk and prognosis of gastrointestinal tumors are reviewed in this paper.

Entities:  

Keywords:  Digestive tract; Matrix metalloproteinase; Promoter region; Single nucleotide polymorphism; Tissue inhibitor of metalloproteinase; cancer

Year:  2011        PMID： 21731908      PMCID： PMC3124635          DOI： 10.4251/wjgo.v3.i6.79

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  109 in total

1.  Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer.

Authors:  Yang Tang; Jinwei Zhu; Ling Chen; Linyin Chen; Sheng Zhang; Jianyin Lin
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

2.  Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival.

Authors:  Lucie E Jones; Michelle J Humphreys; Fiona Campbell; John P Neoptolemos; Mark T Boyd
Journal:  Clin Cancer Res       Date:  2004-04-15       Impact factor: 12.531

3.  Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.

Authors:  S Samantaray; R Sharma; T K Chattopadhyaya; S Datta Gupta; R Ralhan
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-16       Impact factor: 4.553

4.  The association of MMP-1, -3 and -9 genotypes with the prognosis of HCV-related hepatocellular carcinoma patients.

Authors:  Kinya Okamoto; Mari Mandai; Kenichi Mimura; Yoshikazu Murawaki; Isao Yuasa
Journal:  Res Commun Mol Pathol Pharmacol       Date:  2005

5.  A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.

Authors:  Anna Vasků; Monika Goldbergová; Lydie Izakovicová Hollá; Lenka Sisková; Ladislav Groch; Michal Beránek; Svatava Tschöplová; Vladimír Znojil; Jirí Vácha
Journal:  Matrix Biol       Date:  2004-01       Impact factor: 11.583

Review 6.  Regulation of matrix metalloproteinases: an overview.

Authors:  Sajal Chakraborti; Malay Mandal; Sudip Das; Amritlal Mandal; Tapati Chakraborti
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

7.  Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer.

Authors:  Shashi R Harvey; Thelma C Hurd; Gabor Markus; Maisie I Martinick; Remedios M Penetrante; Dongfeng Tan; Preeti Venkataraman; Nisha DeSouza; Sheila N J Sait; Deborah L Driscoll; John F Gibbs
Journal:  Clin Cancer Res       Date:  2003-10-15       Impact factor: 12.531

8.  A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer.

Authors:  Shunji Matsumura; Naohide Oue; Yasuhiko Kitadai; Kazuaki Chayama; Kazuhiro Yoshida; Yoshiyuki Yamaguchi; Tetsuya Toge; Kazue Imai; Kei Nakachi; Wataru Yasui
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-18       Impact factor: 4.553

9.  Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma.

Authors:  M Früh; W Zhou; R Zhai; L Su; R S Heist; J C Wain; N S Nishioka; T J Lynch; F A Shepherd; D C Christiani; G Liu
Journal:  Br J Cancer       Date:  2008-02-05       Impact factor: 7.640

10.  Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer.

Authors:  Y Tanioka; T Yoshida; T Yagawa; Y Saiki; S Takeo; T Harada; T Okazawa; H Yanai; K Okita
Journal:  Br J Cancer       Date:  2003-12-01       Impact factor: 7.640
View more
  9 in total

1.  Association of MMP7 -181A→G Promoter Polymorphism with Gastric Cancer Risk: INFLUENCE OF NICOTINE IN DIFFERENTIAL ALLELE-SPECIFIC TRANSCRIPTION VIA INCREASED PHOSPHORYLATION OF cAMP-RESPONSE ELEMENT-BINDING PROTEIN (CREB).

Authors:  Kousik Kesh; Lakshmi Subramanian; Nillu Ghosh; Vinayak Gupta; Arnab Gupta; Samir Bhattacharya; Nitish R Mahapatra; Snehasikta Swarnakar
Journal:  J Biol Chem       Date:  2015-04-06       Impact factor: 5.157

Review 2.  Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants.

Authors:  Sugreev Verma; Kousik Kesh; Nilanjan Ganguly; Sayantan Jana; Snehasikta Swarnakar
Journal:  World J Biol Chem       Date:  2014-08-26

3.  MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients.

Authors:  A M J Langers; H W Verspaget; L J A C Hawinkels; F J G M Kubben; W van Duijn; J J van der Reijden; J C H Hardwick; D W Hommes; C F M Sier
Journal:  Br J Cancer       Date:  2012-04-24       Impact factor: 7.640

4.  Relationship between single-nucleotide polymorphism of matrix metalloproteinase-2 gene and colorectal cancer and gastric cancer susceptibility: a meta-analysis.

Authors:  Zesheng Wu; Peng Jiang; Haider Zulqarnain; Hua Gao; Wenbin Zhang
Journal:  Onco Targets Ther       Date:  2015-04-16       Impact factor: 4.147

5.  Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.

Authors:  Mujeeb Zafar Banday; Aga Syed Sameer
Journal:  Biosci Rep       Date:  2019-05-10       Impact factor: 3.840

Review 6.  How to place the duality of specific MMP-9 inhibition for treatment of inflammatory bowel diseases into clinical opportunities?

Authors:  Ghislain Opdenakker; Séverine Vermeire; Ahmed Abu El-Asrar
Journal:  Front Immunol       Date:  2022-09-09       Impact factor: 8.786

Review 7.  The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer.

Authors:  László Herszényi; István Hritz; Gábor Lakatos; Mária Zsófia Varga; Zsolt Tulassay
Journal:  Int J Mol Sci       Date:  2012-10-16       Impact factor: 5.923

8.  The influence of matrix metalloproteinase-2, -9, and -12 promoter polymorphisms on Iranian patients with oesophageal squamous cell carcinoma.

Authors:  Haniehsadat Eftekhary; Abed-Ali Ziaee; Mansour Yazdanbod; Mitra Shahpanah; Aziz Setayeshgar; Mojgan Nassiri
Journal:  Contemp Oncol (Pozn)       Date:  2015-08-13

Review 9.  Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal Cancer.

Authors:  Zahra Pezeshkian; Stefania Nobili; Noshad Peyravian; Bahador Shojaee; Haniye Nazari; Hiva Soleimani; Hamid Asadzadeh-Aghdaei; Maziar Ashrafian Bonab; Ehsan Nazemalhosseini-Mojarad; Enrico Mini
Journal:  Cancers (Basel)       Date:  2021-12-10       Impact factor: 6.639
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.